| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/03/2001 | US6255070 Generating preferential polypeptide; express nucleotide sequences which code preferential polypeptide, recover preferential polypeptide |
| 07/03/2001 | US6254875 Methods for use of OMP26 from Haemophilus influenzae |
| 07/03/2001 | US6254870 Amino acid sequences |
| 07/03/2001 | US6254868 Monoclonal antibodies |
| 07/03/2001 | US6254867 Human monoclonal antibodies to the hepatitis B surface antigen |
| 07/03/2001 | CA2116348C Sirs vaccine and diagnosis method |
| 07/03/2001 | CA2012993C Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof |
| 07/03/2001 | CA2009508C Pf 1022 substance, method of producing same and anthelmintic composition containing same |
| 06/28/2001 | WO2001046475A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046453A1 Method for extractive refolding of scrambled single-chain polypeptides |
| 06/28/2001 | WO2001046443A2 Proteases |
| 06/28/2001 | WO2001046422A1 Novel cytokine zcyto18 |
| 06/28/2001 | WO2001046415A1 Novel tachykinin-like polypeptides and use thereof |
| 06/28/2001 | WO2001046390A2 Method of inactivating microorganisms |
| 06/28/2001 | WO2001046383A2 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 06/28/2001 | WO2001046258A2 Transporters and ion channels |
| 06/28/2001 | WO2001046256A2 Vesicle trafficking proteins |
| 06/28/2001 | WO2001046255A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046254A1 Transferrin polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046231A2 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | WO2001046224A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/28/2001 | WO2001045730A2 Tweak receptor |
| 06/28/2001 | WO2001004148A3 Donor strand complemented pilin and adhesin broad-based vaccines |
| 06/28/2001 | WO2001002561A3 Mammalian calcium channels and related probes, cell lines and methods |
| 06/28/2001 | WO2000075305A3 Candida albicans genes and proteins coded by said genes |
| 06/28/2001 | WO2000073344A3 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 06/28/2001 | WO2000071741A3 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
| 06/28/2001 | WO2000070049A3 Extracellular signaling molecules |
| 06/28/2001 | WO2000070047A3 Full-length molecules expressed in human tissues |
| 06/28/2001 | WO2000067697A3 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells |
| 06/28/2001 | WO2000066731A3 Recombinant laminin 5 |
| 06/28/2001 | WO2000066708A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/28/2001 | WO2000061753A3 Compositions and methods for the treatment and diagnosis of breast cancer |
| 06/28/2001 | WO2000055321A3 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 06/28/2001 | WO2000055194A3 Tuberculosis antigens and methods of use therefor |
| 06/28/2001 | WO1999064461A9 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 06/28/2001 | WO1997046686A3 Tumor necrosis factor-related polypeptide |
| 06/28/2001 | WO1997039029A3 An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof |
| 06/28/2001 | US20010005750 Fed-batch cultivation of a microorganism in a bioreactor containing a medium comprising carbon, nitrogen and mineral salt sources, cultivation is carried out by addition of organic carbon source by oscillation feed |
| 06/28/2001 | US20010005747 Bispecific molecules comprising a target cell specific ligand and an effector cell specific antibody or functional antibody fragment |
| 06/28/2001 | DE19962583A1 New antibodies specific for plasma cells, useful for treatment and diagnosis of autoimmune diseases and plasma cell tumors |
| 06/28/2001 | DE19957065A1 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 06/28/2001 | CA2395714A1 Novel tachykinin-like polypeptides and use thereof |
| 06/28/2001 | CA2395525A1 Transferrin polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2395369A1 Cytokine zcyto18 |
| 06/28/2001 | CA2395212A1 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | CA2395007A1 Transporters and ion channels |
| 06/28/2001 | CA2394789A1 Proteases |
| 06/28/2001 | CA2394049A1 Vesicle trafficking proteins |
| 06/28/2001 | CA2394015A1 Tweak receptor |
| 06/28/2001 | CA2392787A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2391594A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies |
| 06/27/2001 | EP1111060A1 A novel human lysozyme gene, its encoding polypeptide and the method for preparing them |
| 06/27/2001 | EP1111059A1 A novel human lysozyme gene, its encoding polypeptide and the method preparing for them |
| 06/27/2001 | EP1111058A1 A novel human lysozyme gene, its encoding polypeptide and the method for preparing them |
| 06/27/2001 | EP1111055A1 Plant enzymes with phospholipid hydroperoxide glutathione peroxidase activity, their analogues and their use |
| 06/27/2001 | EP1111054A1 A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them |
| 06/27/2001 | EP1111053A2 Peptide fragment of the respiratory syncytial virus G protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
| 06/27/2001 | EP1111050A2 Human procalcitonin, its production and use |
| 06/27/2001 | EP1111048A2 Neutral amino acid transporter and gene thereof |
| 06/27/2001 | EP1111047A2 Novel protein and dna thereof |
| 06/27/2001 | EP1111042A1 Antibodies for judging possibility of the onset of bovine leukemia |
| 06/27/2001 | EP1110970A1 Anti-Procalcitonin antibody, their production and use |
| 06/27/2001 | EP1110086A1 Production of motif-specific and context-independent antibodies using peptide libraries as antigens |
| 06/27/2001 | EP1109920A1 Fusion proteins, dna molecules, vectors, and host cells useful for measuring protease activity |
| 06/27/2001 | EP1109911A2 Staphylococcus aureus genes and polypeptides |
| 06/27/2001 | EP1109907A1 Human cell junction pdz protein |
| 06/27/2001 | EP1109906A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
| 06/27/2001 | EP1109905A1 Genes encoding for the human and murine death inducer-obliterator-1 |
| 06/27/2001 | EP1109904A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof |
| 06/27/2001 | EP1109903A2 Human rna-associated proteins |
| 06/27/2001 | EP1109901A2 GABA B RECEPTOR SUBTYPES GABA B-R1c AND GABA B-R2 AND HETERODIMERS THEREOF |
| 06/27/2001 | EP1109895A1 Endothelial cell proliferation inhibitors derived from human prothrombin |
| 06/27/2001 | EP1109833A2 Compositions and methods for the treatment of tumors |
| 06/27/2001 | EP1109829A1 Human latent transforming growth factor beta binding protein 3 |
| 06/27/2001 | EP1109824A1 Novel bag proteins and nucleic acid molecules encoding them |
| 06/27/2001 | EP1109822A1 Factor 8 homologue nucleic acids, polypeptides, methods, uses |
| 06/27/2001 | EP1109821A1 49 human secreted proteins |
| 06/27/2001 | EP1109578A1 Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis |
| 06/27/2001 | EP1109577A1 Multicomponent vaccines |
| 06/27/2001 | EP1109576A2 Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide |
| 06/27/2001 | EP1109566A1 Gcp |
| 06/27/2001 | EP1109565A1 Gabab1aa receptor |
| 06/27/2001 | EP0789750B1 Biological product for the physico-chemical stabilisation of wine |
| 06/27/2001 | EP0724646B1 Dna sequences related to isolated fragile x syndrome |
| 06/27/2001 | EP0690720B1 Therapeutic uses of bactericidal/permeability increasing protein products |
| 06/27/2001 | EP0629131B1 Antigens protective against (echinococcus granulosus) infection and vaccines containing such antigens |
| 06/27/2001 | CN1301309A Method for catalysing complex reactions of large molecules using enzymes which are bonded to a polymer support |
| 06/27/2001 | CN1301307A Methods for producing polypeptides in filamentous fungal mutant cells |
| 06/27/2001 | CN1301306A Methods for producing polypeptides in respiratory-deficient cells |
| 06/27/2001 | CN1301302A Gene encoding labyrinthin, a marker for cancer |
| 06/27/2001 | CN1301299A production of biofilaments in transgenic animals |
| 06/27/2001 | CN1301175A Humanized antibodies that recognize verotoxin II and cell line producing same |
| 06/27/2001 | CN1300851A Pinellia agglutinin protein and its coding sequence |
| 06/27/2001 | CN1300784A Human protein rich in repetitive glutamine sequence and its coding sequence |
| 06/27/2001 | CN1067726C Monoclonal antibody for recognizing interstitial cell surface antigen |
| 06/27/2001 | CN1067721C Hepatitis B surface antigen containing front surface antigen 1 and 2. immunodeterminant |
| 06/26/2001 | US6252051 ErbB4 receptor-specific neuregulin related ligand antibodies and uses therefor |
| 06/26/2001 | US6252050 Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method |
| 06/26/2001 | US6252046 Protein for the treatment of kidney defects |